Abbott Laboratories (NYSE:ABT) shares, rose in value, with the stock price up by 0.19% to the previous day’s close as strong demand from buyers drove the stock to $131.60.
Actively observing the price movement in the recent trading, the stock is buoying the session at $131.35, falling within a range of $131.1 and $133.45. The value of beta (5-year monthly) is 0.693 whereas the PE ratio is 17.18 over 12-month period. Referring to stock’s 52-week performance, its high was $141.23, and the low was $99.71. On the whole, ABT has fluctuated by -3.14% over the past month.
With the market capitalization of Abbott Laboratories currently standing at about $228.24 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Jan-21. The company’s Forward Dividend Ratio is 2.24, with its dividend yield at 1.70%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.62, with the price of ABT currently trading nearly 0.40% and 1.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.52, while the 7-day volatility ratio is showing 2.28% which for the 30-day chart, stands at 2.26%. Furthermore, Abbott Laboratories (ABT)’s beta value is 0.81, and its average true range (ATR) is 2.84.
A comparison of Abbott Laboratories (ABT) with its peers suggests the former has fared considerably weaker in the market. ABT showed an intraday change of 0.19% in today’s session so far, and over the past year, it grew by 18.03%%.
Data on historical trading for Abbott Laboratories (NYSE:ABT) indicates that the trading volumes over the past 10 days have averaged 6.98 and over the past 3 months, they’ve averaged 6.77 million. According to company’s latest data on outstanding shares, there are 1.73 billion shares outstanding.
Nearly 0.67% of Abbott Laboratories’s shares belong to company insiders and institutional investors own 78.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 21.88 million shares as on 2025-03-14, resulting in a short ratio of 3.14. According to the data, the short interest in Abbott Laboratories (ABT) stood at 127.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 22.31 million. The stock has risen by 16.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABT stock heading into the next quarter.
